Literature DB >> 34955656

Prognosis Value of microRNA-3677-3p in Lung Adenocarcinoma and Its Regulatory Effect on Tumor Progression.

Jian Zhao1, Hanbing Yu1, Tianci Han1, Xiangyu Zhu2.   

Abstract

PURPOSE: Lung adenocarcinomas (LUAD) was the most common subtype of lung cancer, and may result in a poor prognosis. This study was designed to explore the role of miR-3677-3p in LUAD and discuss in what way it functions in LUAD.
MATERIALS AND METHODS: We used RT-qPCR method to detect the expression levels of miR-3677-3p in 105 pairs of LUAD tissues and noncancerous tissues, as also as in LUAD cells. We used χ 2 test to analyze the correlation between miR-3677-3p level and the clinical data. The prognosis significance of miR-3677-3p was inferred with Kaplan-Meier and multivariate Cox regression assays. Biological functions of LUAD cells were accessed by cell counting kit-8, transwell migration and invasion assay. The target gene of miR-3677-3p was investigated by luciferase activity assay.
RESULTS: miR-3677-3p represented an ascendant expression in LUAD tissue specimens and cells. miR-3677-3p expression was associated with the TNM stage and with solitary metastasis. Over-expression of miR-3677-3p can shorten the overall survival period of LUAD patients when compared with low expression. Knockdown of miR-3677-3p suppressed the biology function of NSCLC cells including proliferation, migration, and invasion. KLF12 was a target gene of miR-3677-3p.
CONCLUSION: miR-3677-3p represents as a potential prognostic biomarker for LUAD. miR-3677-3p can promote LUAD progression by targeting KLF12.
© 2021 Zhao et al.

Entities:  

Keywords:  KLF12; lung adenocarcinomas; miR-3677-3p; prognosis

Year:  2021        PMID: 34955656      PMCID: PMC8694712          DOI: 10.2147/CMAR.S330357

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


  34 in total

Review 1.  Lung cancer survival only increases by a small amount despite recent treatment advances.

Authors:  Sanjeet Bagcchi
Journal:  Lancet Respir Med       Date:  2017-02-04       Impact factor: 30.700

2.  A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis.

Authors:  Ziqiang Zhang; Yuanqiang Dong; Jin Hua; Hongyuan Xue; Jian Hu; Tao Jiang; Liubin Shi; Jianjun Du
Journal:  Gene       Date:  2019-03-05       Impact factor: 3.688

3.  miR-200a-3p plays tumor suppressor roles in gastric cancer cells by targeting KLF12.

Authors:  Changhe Jia; Yanrui Zhang; Yi Xie; Ying Ren; Haihui Zhang; Yinglei Zhou; Ning Gao; Songze Ding; Shuangyin Han
Journal:  Artif Cells Nanomed Biotechnol       Date:  2019-12       Impact factor: 5.678

4.  Paeonol Inhibits Cell Proliferation, Migration and Invasion and Induces Apoptosis in Hepatocellular Carcinoma by Regulating miR-21-5p/KLF6 Axis.

Authors:  Miaoguo Cai; Wei Shao; Huijun Yu; Ye Hong; Lili Shi
Journal:  Cancer Manag Res       Date:  2020-07-17       Impact factor: 3.989

5.  Dysregulation of Krüppel-like factor 12 in the development of endometrial cancer.

Authors:  Ling Ding; Yi Ding; Xiangyi Kong; Jun Wu; Jian Fu; Guijun Yan; Huaijun Zhou
Journal:  Gynecol Oncol       Date:  2018-10-25       Impact factor: 5.482

6.  Proposal of a Panel of Genes Identified by miRNA Profiling as Candidate Prognostic Biomarkers in Lung Carcinoids.

Authors:  Ida Rapa; Arianna Votta; Jessica Giorcelli; Stefania Izzo; Angelica Rigutto; Jasna Metovic; Francesca Napoli; Marco Volante
Journal:  Neuroendocrinology       Date:  2020-02-11       Impact factor: 4.914

7.  MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.

Authors:  Celia S L Mak; Mingo M H Yung; Lynn M N Hui; Leanne L Leung; Rui Liang; Kangmei Chen; Stephanie S Liu; Yiming Qin; Thomas H Y Leung; Kai-Fai Lee; Karen K L Chan; Hextan Y S Ngan; David W Chan
Journal:  Mol Cancer       Date:  2017-01-17       Impact factor: 27.401

8.  Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.

Authors:  Namhee Yu; Seunghui Yong; Hong Kwan Kim; Yoon-La Choi; Yeonjoo Jung; Doyeon Kim; Jihae Seo; Ye Eun Lee; Daehyun Baek; Jinseon Lee; Seungjae Lee; Jong Eun Lee; Jaesang Kim; Jhingook Kim; Sanghyuk Lee
Journal:  Mol Oncol       Date:  2019-04-18       Impact factor: 6.603

9.  The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells.

Authors:  Chen Yao; Jian-Wei Ruan; Yun-Rong Zhu; Fei Liu; Hui-Ming Wu; Yan Zhang; Qing Jiang
Journal:  Aging (Albany NY)       Date:  2020-03-23       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.